D-dimers increase in acute ischemic stroke patients with the large artery occlusion, but do not depend on the time of artery recanalization

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 477-482

  Školoudík, David ^a,b   Bar, Michal ^a   Šaňák, Daniel ^b   Bardoň, Petr ^c   Roubec, Martin ^a   Langová, Kateřina ^b   Herzig, Roman ^b   Kaňovský, Petr ^b  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Hospital T inec   (Czech Republic)

Author keywords

Artery recanalization; D dimers; Fibrinolytic system; Stroke; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; D DIMER; FIBRINOGEN; FIBRINOLYTIC AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYTIC THERAPY; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ACUTE DISEASE; BLOOD; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; STROKE; TIME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTRACRANIAL ARTERIAL DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STROKE; TIME FACTORS;

EID: 77953904158     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0372-9     Document Type: Article

References (35)

1. Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA (2004) Stroke: pathophysiology, diagnosis, and management, 4th edn. Elsevier Inc, Philadelphia
2. Hacke W, Donnan G, Fieschi C, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators et al (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774
3. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW, CLOTBUST Investigators (2004) Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351:2170-2178
4. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabín J, CLOTBUST Investigators (2004) Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 35:151-156 (Pubitemid 38057610)
5. Alexandrov AV, Babikian VL, Adams RJ, Tegeler CH, Caplan LR, Spencer MP, National Stroke Association Panelists on Transcranial Doppler (1998) The evolving role of transcranial Doppler in stroke prevention and treatment. J Stroke Cerebrovasc Dis 7:101-104
6. Bar M, Skoloudík D, Roubec M, Hradílek P, Chmelová J, Czerný D, Procházka V, Langová K, Herzig R (2009) Transcranial duplex sonography and CT angiography in acute stroke patients. J Neuroimaging Feb. 13 [Epub ahead of print]
7. Sie P (1995) The value of laboratory tests in the diagnosis of venous thrombembolism. Haematologica 80:57-60
8. Lowe G (2005) Fibrin D-dimer and cardiovascular risk. Semin Vasc Med 5:387-398
9. Haapaniemi E, Tatlisumak T (2009) Is D-dimer helpful in evaluating stroke patients? A systematic review. Acta Neurol Scand 119:141-150
10. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, Didier D, Unger PF, Patenaude JV, Bounameaux H (1999) Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 353:190-195
11. Dunn KL, Wolf JP, Dorfman DM, Fitzpatrick P, Baker JL, Goldhaber SZ (2002) Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 40:1475-1478
12. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S et al (1998) Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation 98:2527-2533
13. Skoloudík D, Bar M, Zapletalová O, Langová K, Herzig R, Kanovský P (2007) D-dimer levels in acute stroke patients. Cesk Slov Neurol N 103:375-379
14. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457-507
15. Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, Venco A (2002) Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 162:2589-2593
16. Takano K, Yamaguchi T, Uchida K (1992) Markers of a hypercoagulable state following acute ischemic stroke. Stroke 23:194-198
17. Jin L, Jin H, Zhang G, Xu G (2000) Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase. Clin Hemorheol Microcirc 23:213-218
18. Barber M, Langhorne P, Rumley A, Lowe G, Stott D (2004) Hemostatic function and progressing ischemic stroke. Stroke 35:1421-1425
19. Audebert HJ, Pellkofer TS, Wimmer ML, Habert RL (2004) Progression in lacunar stroke is related to elevated acute acute phase parameters. Eur Neurol 51:125-131
20. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J (2008) Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39:2280-2287
21. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ (2009) Association of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 27:247-253
22. Zivković M, Brkić K, Nikić N, Hasperger D, Juricek J, Husedzinović I, Sutlić Z (2005) Monitoring of fibrinolysis parameters during myocardial revascularization according to type of procedure. Clin Chem Lab Med 43:43-48
23. Fassbender K, Dempfle CE, Mielke O, Schwartz A, Daffertshofer M, Eschenfelder C, Dollman M, Hennerici M (1999) Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke 30:2101-2104
24. Lip GY, Blann AD, Farooqi IS, Zarifis J, Sagar G, Beevers DG (2002) Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project. Blood Coagul Fibrinolysis 13:339-347
25. Collen D (1988) Plasminogen activators and thrombolytic therapy. IS1 Atlas of Science. Pharmacology 3:116-121
26. Butler SP, Kader KL, Owen J, Wang TS, Fawwaz RA, Alderson PO (1991) Rapid localization of indium-111-labeled inhibited recombinant tissue plasminogen activator in a rabbit thrombosis model. J Nucl Med 32:461-467
27. Ince B, Bayram C, Harmanci H, Ulutin T (1999) Hemostatic markers in ischemic stroke of undetermined etiology. Thromb Res 96:169-174
28. Kelly J, Rudd A, Lewis RR, Parmar K, Moody A, Hunt BJ (2003) The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness. Blood Coagul Fibrinolysis 14:639-645
29. Collen D, Liknej HR (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114-3124
30. Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS, Schwarz K, Marder JV (1992) Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 90:2063-2068
31. Daffertshofer M, Fatar M (2002) Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur J Ultrasound 16:121-130
32. Skoloudík D, Fadrná T, Bar M, Zapletalová O, Zapletal O, Blatný J, Penka M, Langová K, Hlustík P, Herzig R, Kanovský P (2008) Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2-4 MHz transcranial probe. J Thromb Thrombolysis 26:119-124
33. Berge E, Friis P, Sandset PM (2001) Hemostatic activation in acute ischemic stroke. Thromb Res 101:13-21
34. Tombul T, Atbas C, Anlar O (2005) Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. J Clin Neurosci 12:429-434
35. Feinberg WM, Erickson LP, Bruck D, Kittelson J (1996) Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. Stroke 27:1296-1300